Bioventus Inc. (BVS) NASDAQ
7.97
+0.0405(+0.51%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.97
+0.0405(+0.51%)
Currency In USD
| Market Cap | 495.67M |
| Enterprise Value | 755.78M |
| P/E Ratio | 18.83 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.94 |
| Price/Book Ratio | 2.84 |
| Enterprise/Revenue | 0.91 |
| Enterprise/EBITDA | 4.86 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 28, 2026 |
| Profit Margin | 0.05 |
| Operating Margin | 0.11 |
| Return On Assets | 0.04 |
| Return On Equity | 0.16 |
| Revenue | 568.09M |
| Revenue/Share | 8.56 |
| Gross Profit | 382.43M |
| EBITDA | 105.56M |
| Net Income | 22.73M |
| Diluted EPS | 0.33 |
| Total Cash | 35.85M |
| Total Cash/Share | 0.53 |
| Total Debt | 18.75M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 1.69 |
| Book Value Per Share | 3.48 |
| 52-Week Change | 23.77 |
| 52-Week High | 11.25 |
| 52-Week Low | 5.81 |
| Moving Average 50 Days | 9.69 |
| Moving Average 200 Days | 8.09 |
| Average Volume | 526,426 |
| Shares Outstanding | 67.75M |
| % Held by Institutions | 76.64 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |